Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07294599Not ApplicableNot Yet Recruiting

Morning Versus Evening Patching in Childhood Amblyopia

Role: lead

NCT06766227Not ApplicableNot Yet Recruiting

Smoking Cessation App. in Arabic

Role: lead

NCT06412380Not ApplicableCompleted

Influence of Insertion Torque and Bone Type on Post-operative Pain

Role: collaborator

NCT06289816Completed

Spleen Preserving Surgery for Splenic Hydatidosis: A Cohort Study on Short and Long-Term Outcomes

Role: lead

NCT06077682Phase 4Unknown

Cycloplegic Refraction in Pediatric Patients With Esotropia

Role: collaborator

NCT05106803Completed

Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan

Role: lead

NCT04650035Completed

The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak

Role: lead

All 7 trials loaded